**EPIC EHR â€“ INPATIENT PROGRESS NOTE**  
**Patient:** Leon Herman  
**MRN:** 00439281  
**DOB:** 2000-05-05 (Age: 23)  
**Sex:** Male  
**Date of Admission:** 2024-05-14  
**Attending:** Dr. S. Patel  
**Location:** MICU, Bed 8  

---

### CHIEF COMPLAINT  
"Shortness of breath, chest pain, and near-syncope"

---

### HISTORY OF PRESENT ILLNESS  
23-year-old male with h/o hypertension, childhood asthma, perennial allergic rhinitis, and remote orthopedic injuries (L ankle sprain, R wrist subluxation/fracture) who presented to the ED with 2 days of progressive dyspnea, orthopnea, and intermittent chest discomfort. On arrival, found to be tachycardic (HR 132), hypotensive (BP 88/54), and hypoxic (SpO2 89% RA). He rapidly decompensated with evidence of cardiogenic shock (cool extremities, altered mentation, oliguria). Emergent echo revealed severe global LV systolic dysfunction (EF 15%), moderate MR, and no RV involvement. No previous cardiac history. Transferred to ICU for vasopressor support and evaluation for advanced therapies.  

Due to ongoing hemodynamic instability despite maximal medical therapy (dobutamine, norepinephrine), decision made for placement of a percutaneous left ventricular assist device (Impella CP) on HD2. Subsequent stabilization, weaning of pressors, and ongoing workup for underlying etiology (viral myocarditis suspected, workup pending; negative tox, no ischemia on serial troponins).   

---

### PAST MEDICAL HISTORY  
- Hypertension (dx age 19, poorly controlled)  
- Childhood asthma (mild, intermittent)  
- Allergic rhinitis (perennial)  
- Viral sinusitis (intermittent, last episode 2 months ago)  
- Orthopedic: L ankle sprain (2019), R wrist subluxation/fracture (2018, resolved)  

### PAST SURGICAL HISTORY  
- None

### FAMILY HISTORY  
- Father: HTN, CAD  
- Mother: Asthma  
- No known inherited cardiomyopathies

### SOCIAL HISTORY  
- Non-smoker, rare ETOH, no illicit drugs  
- Lives with roommates, college student  
- No recent travel, sick contacts

### ALLERGIES  
- NKDA

---

### HOME MEDICATIONS  
- Fexofenadine 30 mg PO QD  
- Fluticasone 0.044 mg/actuation INH BID  
- Albuterol 0.09 mg/actuation INH PRN  
- Epinephrine 1mg/mL auto-injector PRN  
- Acetaminophen 325 mg PO PRN  
- HCTZ 12.5 mg PO QD  
- Atenolol 50 mg / Chlorthalidone 25 mg PO QD  
- Amlodipine 5 mg / HCTZ 12.5 mg / Olmesartan 20 mg PO QD  

---

### PHYSICAL EXAM (HD3, post-Impella)  
- Gen: Appears tired, in no acute distress  
- Vitals: T 36.9C, HR 94 (Impella), BP 102/66 (MAP 78), RR 18, SpO2 96% (2L NC)  
- HEENT: PERRLA, oropharynx clear  
- Lungs: Bibasilar crackles, mild expiratory wheeze  
- CV: S1/S2, soft S3, no murmur; Impella hum audible; pulses 2+  
- Abd: Soft, NT, no HSM  
- Ext: No edema, warm, cap refill <2s  
- Neuro: AO x3, no focal deficit  

---

## LABS

#### CBC + CHEM7 (selected, ICU days 1-5)

| Date         | WBC (K/uL) | Hgb (g/dL) | Hct (%) | Plt (K/uL) | Na (mmol/L) | K (mmol/L) | Cl (mmol/L) | CO2 (mmol/L) | BUN (mg/dL) | Cr (mg/dL) | Glu (mg/dL) |
|--------------|------------|------------|---------|------------|-------------|------------|-------------|--------------|-------------|------------|-------------|
| 5/14 (ED)    | 14.2       | 15.8       | 47.6    | 230        | 137         | 5.4        | 99          | 21           | 32          | 1.7        | 122         |
| 5/15 (HD1)   | 12.6       | 14.1       | 42.2    | 194        | 135         | 4.9        | 97          | 18           | 41          | 2.1        | 108         |
| 5/16 (HD2)   | 10.7       | 13.2       | 39.8    | 158        | 138         | 4.2        | 100         | 22           | 36          | 1.5        | 112         |
| 5/17 (HD3)   | 9.9        | 12.4       | 37.0    | 135        | 139         | --         | 101         | 23           | 28          | 1.3        | 106         |
| 5/18 (HD4)   | 8.4        | 11.7       | 35.1    | 128        | --          | 4.1        | 98          | 24           | 21          | 1.1        | --          |

#### ADDITIONAL LABS

| Date         | Troponin I (ng/mL) | BNP (pg/mL) | AST (U/L) | ALT (U/L) | Alk Phos (U/L) | T.bili (mg/dL) | INR  |
|--------------|--------------------|-------------|-----------|-----------|---------------|----------------|-------|
| 5/14         | 0.07               | 3212        | 61        | 73        | 104           | 1.2            | 1.3   |
| 5/15         | 0.06               | 3880        | 75        | 96        | 117           | 1.4            | 1.5   |
| 5/16         | 0.04               | 3341        | 52        | 62        | --            | 1.1            | 1.2   |
| 5/18         | <0.01              | 2101        | 39        | 49        | 89            | --             | 1.0   |

---

### MICROBIOLOGY / SEROLOGY
- Viral panel: Pending (Coxsackie, Parvo, Adenovirus, Influenza, RSV)
- Blood cultures x2: No growth at 48h
- COVID-19 PCR: Negative
- ANA/DSDNA: Pending

---

### RADIOLOGY  
- **CXR (5/14):** Cardiomegaly, pulmonary edema  
- **Echo (5/14):** Severe LV systolic dysfunction (EF 15%), moderate MR, no RV dysfunction, no pericardial effusion  
- **Repeat Echo (5/17):** LV EF improved to 31% (Impella in situ), MR mild, no LV thrombus  

---

## ASSESSMENT & PLAN

**23M with new severe non-ischemic cardiomyopathy (likely myocarditis) and cardiogenic shock, s/p Impella CP LVAD placement.**

### PROBLEM-BASED LIST

1. **Cardiogenic shock, new severe LV dysfunction (EF 15%)**
   - Etiology: Suspected viral myocarditis vs. other non-ischemic cause (no CAD risk factors, neg trops, unremarkable tox)
   - Management: 
     - Pressors/inotropes (weaned off by HD3)
     - Impella CP placed HD2 for circulatory support; flows 3.2-3.6 L/min
     - Serial TTEs: improving EF, stable device position
     - Strict I/O, daily weights, diuresis as tolerated
     - Plan: Continue Impella, reassess for weaning/removal HD5-6 if stable
2. **Hypertension**
   - Previously poorly controlled, now labile with shock
   - Held PO anti-HTNs, titrating as tolerated
   - Plan: Resume oral agents as hemodynamics allow
3. **Acute Kidney Injury (pre-renal, resolving)**
   - Initial Cr up to 2.1, now 1.1, likely 2/2 low perfusion
   - Monitored UOP, adjusted diuretics, improved with Impella
   - Plan: Monitor, avoid nephrotoxins, rehydrate as tolerated
4. **Mild transaminitis**
   - AST/ALT peaked HD1-2, likely shock liver, trending down
   - Plan: Monitor LFTs, avoid hepatotoxins
5. **Respiratory failure, mild**
   - Mild pulmonary edema, O2 via NC, improved after diuresis
   - Asthma hx, no active wheeze or need for nebs
   - Plan: Monitor, PRN inhalers, pulmonary toilet
6. **Thromboprophylaxis**
   - On heparin per Impella protocol, SCDs
   - Platelets trending down but >100K, monitor for HIT
7. **Infection risk**
   - No evidence of secondary infection
   - Blood cultures negative, viral studies pending
   - Plan: Monitor, remove lines ASAP
8. **Nutrition**
   - Mildly malnourished on admit (BMI ~19.9)
   - Started on enteral feeds, TPN not indicated
9. **Pain**
   - Mild, s/p device placement, well-controlled on acetaminophen
10. **Psychosocial**
    - College student, anxious re: prognosis
    - Social work and psych consults placed

---

### DISPOSITION  
- Remain in ICU, daily assessment for Impella weaning/removal  
- If stable and EF recovers, stepdown to telemetry  
- Close f/u with Heart Failure/Cardiology, consider wearable defibrillator  

---

### SIGNED  
Dr. S. Patel, MD  
Cardiology / Critical Care  
Date/Time: 2024-05-18 09:22

---

**END OF NOTE**
